Atacicept Terminated Phase 2 Trials for Systemic Lupus Erythematosus (SLE) Treatment

Back to Atacicept
IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02070978Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II)